# Cantabio Pharmaceuticals Inc.

Cantabio Pharmaceuticals Inc. is a company headquartered in Palo Alto, CA, United States.

## Company overview

- **Legal name:** Cantabio Pharmaceuticals Inc.
- **Former names in filing history:** Lion Consulting Group Inc. (2012-05-23 to 2015-08-26)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Palo Alto, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** March 31
- **SEC CIK:** 0001550518

## About

Cantabio Pharmaceuticals Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001550518, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2018-07-16, it reported net income of USD -2,011,773; total assets of USD 109,426 for the fiscal period ended 2018-03-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2018 (period ended 2018-03-31)

- **Net income:** -$2.0M (USD -2,011,773)
- **Total assets:** $109,426 (USD 109,426)
- **Cash and equivalents:** $109,426 (USD 109,426)
- **Operating cash flow:** -$623,349 (USD -623,349)

### FY2017 (period ended 2017-03-31)

- **Net income:** -$1.1M (USD -1,112,138)
- **Total assets:** $33,523 (USD 33,523)
- **Cash and equivalents:** $32,275 (USD 32,275)
- **Operating cash flow:** -$973,120 (USD -973,120)

### FY2016 (period ended 2016-03-31)

- **Net income:** -$751,328 (USD -751,328)
- **Total assets:** $52,110 (USD 52,110)
- **Cash and equivalents:** $52,110 (USD 52,110)
- **Operating cash flow:** -$564,660 (USD -564,660)

### FY2015 (period ended 2015-03-31)

- **Net income:** -$25,322 (USD -25,322)
- **Operating cash flow:** -$13,371 (USD -13,371)
- **Later filings:** Net income, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2019-06-21 — period 2019-06-21 — CURRENT REPORT
- Form 10-Q — filed 2019-06-17 — period 2018-12-31 — QUARTERLY REPORT
- Form 8-K — filed 2019-03-21 — period 2019-03-13 — CURRENT REPORT
- Form 8-K — filed 2018-12-14 — period 2018-11-23 — CURRENT REPORT
- Form 10-Q — filed 2018-11-13 — period 2018-09-30 — QUARTERLY REPORT
- Form 8-K — filed 2018-10-15 — period 2018-09-07 — PRIMARY DOCUMENT
- Form 10-Q — filed 2018-08-20 — period 2018-06-30 — PRIMARY DOCUMENT
- Form 10-K — filed 2018-07-16 — period 2018-03-31 — PRIMARY DOCUMENT
- Form 8-K — filed 2018-06-08 — period 2018-06-05 — PRIMARY DOCUMENT
- Form 8-K — filed 2018-04-11 — period 2018-01-12 — PRIMARY DOCUMENT
- Form 10-Q — filed 2018-02-20 — period 2017-12-31 — PRIMARY DOCUMENT
- Form 8-K — filed 2017-11-27 — period 2017-11-20 — PRIMARY DOCUMENT

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/cantabio-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology